205 related articles for article (PubMed ID: 24931594)
1. Dynamic contrast-enhanced magnetic resonance imaging: applications in oncology.
Teo QQ; Thng CH; Koh TS; Ng QS
Clin Oncol (R Coll Radiol); 2014 Oct; 26(10):e9-20. PubMed ID: 24931594
[TBL] [Abstract][Full Text] [Related]
2. Functional tumor imaging with dynamic contrast-enhanced magnetic resonance imaging.
Choyke PL; Dwyer AJ; Knopp MV
J Magn Reson Imaging; 2003 May; 17(5):509-20. PubMed ID: 12720260
[TBL] [Abstract][Full Text] [Related]
3. Contrast enhanced MR imaging of female pelvic cancers: established methods and emerging applications.
Punwani S
Eur J Radiol; 2011 Apr; 78(1):2-11. PubMed ID: 20381276
[TBL] [Abstract][Full Text] [Related]
4. Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker.
Hylton N
J Clin Oncol; 2006 Jul; 24(20):3293-8. PubMed ID: 16829653
[TBL] [Abstract][Full Text] [Related]
5. Dynamic contrast-enhanced MRI studies in oncology with an emphasis on quantification, validation and human studies.
Padhani AR; Husband JE
Clin Radiol; 2001 Aug; 56(8):607-20. PubMed ID: 11467863
[TBL] [Abstract][Full Text] [Related]
6. Dynamic contrast enhanced (DCE) magnetic resonance imaging (MRI) of atherosclerotic plaque angiogenesis.
Calcagno C; Mani V; Ramachandran S; Fayad ZA
Angiogenesis; 2010 Jun; 13(2):87-99. PubMed ID: 20526859
[TBL] [Abstract][Full Text] [Related]
7. The role of dynamic contrast-enhanced and diffusion weighted magnetic resonance imaging in the female pelvis.
Sala E; Rockall A; Rangarajan D; Kubik-Huch RA
Eur J Radiol; 2010 Dec; 76(3):367-85. PubMed ID: 20810230
[TBL] [Abstract][Full Text] [Related]
8. Dynamic contrast-enhanced magnetic resonance imaging for assessing tumor vascularity and vascular effects of targeted therapies in renal cell carcinoma.
Rosen MA; Schnall MD
Clin Cancer Res; 2007 Jan; 13(2 Pt 2):770s-776s. PubMed ID: 17255308
[TBL] [Abstract][Full Text] [Related]
9. Perfusion and vascular permeability: basic concepts and measurement in DCE-CT and DCE-MRI.
Cuenod CA; Balvay D
Diagn Interv Imaging; 2013 Dec; 94(12):1187-204. PubMed ID: 24211260
[TBL] [Abstract][Full Text] [Related]
10. A review of technical aspects of T1-weighted dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) in human brain tumors.
Bergamino M; Bonzano L; Levrero F; Mancardi GL; Roccatagliata L
Phys Med; 2014 Sep; 30(6):635-43. PubMed ID: 24793824
[TBL] [Abstract][Full Text] [Related]
11. Diffusion and perfusion imaging of bone marrow.
Biffar A; Dietrich O; Sourbron S; Duerr HR; Reiser MF; Baur-Melnyk A
Eur J Radiol; 2010 Dec; 76(3):323-8. PubMed ID: 20381277
[TBL] [Abstract][Full Text] [Related]
12. Dynamic contrast-enhanced MRI in oncology: how we do it.
Petralia G; Summers PE; Agostini A; Ambrosini R; Cianci R; Cristel G; Calistri L; Colagrande S
Radiol Med; 2020 Dec; 125(12):1288-1300. PubMed ID: 32415476
[TBL] [Abstract][Full Text] [Related]
13. Pathological animal models in the experimental evaluation of tumour microvasculature with magnetic resonance imaging.
Faccioli N; Marzola P; Boschi F; Sbarbati A; D'Onofrio M; Pozzi Mucelli R
Radiol Med; 2007 Apr; 112(3):319-28. PubMed ID: 17440699
[TBL] [Abstract][Full Text] [Related]
14. Absolute quantification of regional renal blood flow in swine by dynamic contrast-enhanced magnetic resonance imaging using a blood pool contrast agent.
Lüdemann L; Nafz B; Elsner F; Grosse-Siestrup C; Meissler M; Kaufels N; Rehbein H; Persson PB; Michaely HJ; Lengsfeld P; Voth M; Gutberlet M
Invest Radiol; 2009 Mar; 44(3):125-34. PubMed ID: 19151609
[TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance imaging (MRI) and dynamic MRI evaluation of extranodal non-Hodgkin lymphoma in oral and maxillofacial regions.
Matsuzaki H; Hara M; Yanagi Y; Asaumi J; Katase N; Unetsubo T; Hisatomi M; Konouchi H; Takenobu T; Nagatsuka H
Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Jan; 113(1):126-33. PubMed ID: 22669071
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
[TBL] [Abstract][Full Text] [Related]
17. Dynamic contrast-enhanced magnetic resonance imaging in oncology.
Knopp MV; Giesel FL; Marcos H; von Tengg-Kobligk H; Choyke P
Top Magn Reson Imaging; 2001 Aug; 12(4):301-8. PubMed ID: 11687716
[TBL] [Abstract][Full Text] [Related]
18. Dynamic contrast-enhanced MRI in clinical oncology: current status and future directions.
Padhani AR
J Magn Reson Imaging; 2002 Oct; 16(4):407-22. PubMed ID: 12353256
[TBL] [Abstract][Full Text] [Related]
19. SElf-gated Non-Contrast-Enhanced FUnctional Lung imaging (SENCEFUL) using a quasi-random fast low-angle shot (FLASH) sequence and proton MRI.
Fischer A; Weick S; Ritter CO; Beer M; Wirth C; Hebestreit H; Jakob PM; Hahn D; Bley T; Köstler H
NMR Biomed; 2014 Aug; 27(8):907-17. PubMed ID: 24820869
[TBL] [Abstract][Full Text] [Related]
20. Reproducibility of the aortic input function (AIF) derived from dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) of the kidneys in a volunteer study.
Mendichovszky IA; Cutajar M; Gordon I
Eur J Radiol; 2009 Sep; 71(3):576-81. PubMed ID: 19004588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
